Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy.
Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight loss.

CGT scale back for property investors; tech stocks hammered; $US500b crypto sell-off
17:22

Q+A: After all the hype, green investing is 'growing up, not winding down'
11:31

Afternoon Report | Miners lift ASX
04:38